FDA: PCNS Drugs Advisory Committee Results for Avid's Amyvid Alzheimer's Amyloid Neuroimaging Agent
F.D.A. Sees Promise in Alzheimer’s Imaging Drug
By GINA KOLATA
The New York Times
Published: January 20, 2011
"A committee voted that the agency should approve the first test that can show the characteristic plaques of Alzheimer’s disease in the brain of a living person."
Read the full article